Bumper Offer - Urjas oil Just @ Rs. 1
Nimdase P is a commercial drug that is prescribed in the form of Tablet. Primarily, it is used for the treatment of Fever, Pain, Fever. Secondary and off-label uses of Nimdase P have also been mentioned below.
Medical history of the patient along with age and gender determines the dosage of Nimdase P. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
Some other side effects of Nimdase P have been listed ahead. Usually, these side effects of Nimdase P go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Furthermore, you should know that effect of Nimdase P is Moderate for pregnant women and Moderate for women who are breastfeeding. It is important to know if Nimdase P has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Nimdase P related warnings section.
Nimdase P can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Nimdase P in conditions like Liver Disease, Kidney Disease, Liver Disease. Other conditions have been mentioned below in the Nimdase P contraindications section.
Drug interactions for Nimdase P have been reported in the medical literature. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Nimdase P is considered safe while driving, and is addictive.
Nimdase P is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Based on research, the following side effects have been observed when Nimdase P is used -
Severe
Moderate
Mild
Is the use of Nimdase P safe for pregnant women?
Nimdase P may have some side effects during pregnancy. Pregnant women should discontinue the use of Nimdase P, and talk to their doctor, if they notice any discomfort.
Is the use of Nimdase P safe during breastfeeding?
Nimdase P may lead to some side effects in breastfeeding women. If you witness any unusal symptoms after taking Nimdase P, discontinue its use and call your doctor right away. Follow your doctor's advice regarding the use of Nimdase P.
What is the effect of Nimdase P on the Kidneys?
Very few cases of side effects of Nimdase P on kidney have been reported.
What is the effect of Nimdase P on the Liver?
Nimdase P is rarely harmful for the liver.
What is the effect of Nimdase P on the Heart?
Nimdase P has very mild side effects on the heart.
Nimdase P should not be taken with following medicines due to severe side effects it may cause to patients -
Life Threatening
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Nimdase P unless your doctor advises you to do so -
Is this Nimdase P habit forming or addictive?
No, there is no any evidence that Nimdase P is addictive.
Interaction between Food and Nimdase P
Due to the absence of research, it is difficult to say how Nimdase P and food will interact.
Interaction between Alcohol and Nimdase P
It is difficult to say anything about the effect of Nimdase P and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 203-204
KD Tripathi. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 206-207
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Acetaminophen (acetaminophen)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ofirmev (acetaminophen)
